Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial.
利拉鲁肽可改善 2 型糖尿病合并外周动脉疾病患者的外周灌注以及血管生成和炎症标志物：一项随机临床试验的 18 个月随访
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16419
Caruso Paola, Maiorino Maria Ida, Longo Miriam, Maio Antonietta, Scappaticcio Lorenzo, Di Martino Nicole, Carbone Carla, Barrasso Mariluce, Caputo Mariangela, Gicchino Maurizio, Bellastella Giuseppe, Giugliano Dario, Esposito Katherine
